- THIS ARTICLE
- Full Text
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Shriner, D.
- Articles by Mullins, J. I.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Shriner, D.
- Articles by Mullins, J. I.
Genetics, Vol. 167, 1573-1583, August 2004, Copyright © 2004
doi:10.1534/genetics.103.023382
Pervasive Genomic Recombination of HIV-1 in Vivo
Daniel Shriner*,1,
Allen G. Rodrigo*,2,
David C. Nickle* and
James I. Mullins*,
* Department of Microbiology, University of Washington School of Medicine, Seattle, Washington 98195-8070
Departments of Medicine and Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington 98195-8070
1 Corresponding author: Department of Microbiology, Rosen Bldg., University of Washington School of Medicine, Box 358070, Seattle, WA 98195-8070.
E-mail: dshriner{at}u.washington.edu
Recombinants of preexisting human immunodeficiency virus type 1 (HIV-1) strains are now circulating globally. To increase our understanding of the importance of these recombinants, we assessed recombination within an individual infected from a single source by studying the linkage patterns of the auxiliary genes of HIV-1 subtype B. Maximum-likelihood phylogenetic techniques revealed evidence for recombination from topological incongruence among adjacent genes. Coalescent methods were then used to estimate the in vivo recombination rate. The estimated mean rate of 1.38 x 104 recombination events/adjacent sites/generation is
5.5-fold greater than the reported point mutation rate of 2.5 x 105/site/generation. Recombination was found to be frequent enough to mask evidence for purifying selection by Tajima's D test. Thus, recombination is a major evolutionary force affecting genetic variation within an HIV-1-infected individual, of the same order of magnitude as point mutational change.
This article has been cited by other articles:
![]() |
N. N. V. Vijay, Vasantika, R. Ajmani, A. S. Perelson, and N. M. Dixit Recombination increases human immunodeficiency virus fitness, but not necessarily diversity J. Gen. Virol., June 1, 2008; 89(6): 1467 - 1477. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Keele, E. E. Giorgi, J. F. Salazar-Gonzalez, J. M. Decker, K. T. Pham, M. G. Salazar, C. Sun, T. Grayson, S. Wang, H. Li, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection PNAS, May 27, 2008; 105(21): 7552 - 7557. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Salazar-Gonzalez, E. Bailes, K. T. Pham, M. G. Salazar, M. B. Guffey, B. F. Keele, C. A. Derdeyn, P. Farmer, E. Hunter, S. Allen, et al. Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing J. Virol., April 15, 2008; 82(8): 3952 - 3970. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nora, C. Charpentier, O. Tenaillon, C. Hoede, F. Clavel, and A. J. Hance Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral Treatment J. Virol., July 15, 2007; 81(14): 7620 - 7628. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Rousseau, G. H. Learn, T. Bhattacharya, D. C. Nickle, D. Heckerman, S. Chetty, C. Brander, P. J. R. Goulder, B. D. Walker, P. Kiepiela, et al. Extensive Intrasubtype Recombination in South African Human Immunodeficiency Virus Type 1 Subtype C Infections J. Virol., May 1, 2007; 81(9): 4492 - 4500. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. da Silva Site-Specific Amino Acid Frequency, Fitness and the Mutational Landscape Model of Adaptation in Human Immunodeficiency Virus Type 1 Genetics, November 1, 2006; 174(3): 1689 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Baird, R. Galetto, Y. Gao, E. Simon-Loriere, M. Abreha, J. Archer, J. Fan, D. L. Robertson, E. J. Arts, and M. Negroni Sequence determinants of breakpoint location during HIV-1 intersubtype recombination Nucleic Acids Res., October 6, 2006; (2006) gkl669v3. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Carvajal-Rodriguez, K. A. Crandall, and D. Posada Recombination Estimation Under Complex Evolutionary Models with the Coalescent Composite-Likelihood Method Mol. Biol. Evol., April 1, 2006; 23(4): 817 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Poss, H. A. Ross, S. L. Painter, D. C. Holley, J. A. Terwee, S. VandeWoude, and A. Rodrigo Feline Lentivirus Evolution in Cross-Species Infection Reveals Extensive G-to-A Mutation and Selection on Key Residues in the Viral Polymerase J. Virol., March 15, 2006; 80(6): 2728 - 2737. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Charpentier, T. Nora, O. Tenaillon, F. Clavel, and A. J. Hance Extensive Recombination among Human Immunodeficiency Virus Type 1 Quasispecies Makes an Important Contribution to Viral Diversity in Individual Patients J. Virol., March 1, 2006; 80(5): 2472 - 2482. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pastore, R. Nedellec, A. Ramos, S. Pontow, L. Ratner, and D. E. Mosier Human Immunodeficiency Virus Type 1 Coreceptor Switching: V1/V2 Gain-of-Fitness Mutations Compensate for V3 Loss-of-Fitness Mutations J. Virol., January 15, 2006; 80(2): 750 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Zaunders, M. L. Munier, D. E. Kaufmann, S. Ip, P. Grey, D. Smith, T. Ramacciotti, D. Quan, R. Finlayson, J. Kaldor, et al. Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection Blood, September 1, 2005; 106(5): 1660 - 1667. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Joos, A. Trkola, M. Fischer, H. Kuster, P. Rusert, C. Leemann, J. Boni, A. Oxenius, D. A. Price, R. E. Phillips, et al. Low Human Immunodeficiency Virus Envelope Diversity Correlates with Low In Vitro Replication Capacity and Predicts Spontaneous Control of Plasma Viremia after Treatment Interruptions J. Virol., July 15, 2005; 79(14): 9026 - 9037. [Abstract] [Full Text] [PDF] |
||||






